缩写名/全名 |
PHARMACOGENET GENOM
Pharmacogenetics and Genomics |
||||||||||||||||||||||||||||
ISSN号 | 1744-6872 | ||||||||||||||||||||||||||||
研究方向 | 医学-生物工程与应用微生物 | ||||||||||||||||||||||||||||
影响因子 | 2015:2.857, 2016:2.184, 2017:2.25, 2018:2.693, 2019:2.628, | ||||||||||||||||||||||||||||
出版国家 | UNITED STATES | ||||||||||||||||||||||||||||
出版周期 | Monthly | ||||||||||||||||||||||||||||
年文章数 | 33 | ||||||||||||||||||||||||||||
出版年份 | 2005 | ||||||||||||||||||||||||||||
是否OA | No | ||||||||||||||||||||||||||||
审稿周期(仅供参考) | 平均3.0个月 |
||||||||||||||||||||||||||||
录用比例 | 约5% | ||||||||||||||||||||||||||||
投稿链接 | http://www.editorialmanager.com/pgen/default.aspx | ||||||||||||||||||||||||||||
投稿官网 | http://journals.lww.com/jpharmacogenetics/pages/default.aspx | ||||||||||||||||||||||||||||
h-index | 134 | ||||||||||||||||||||||||||||
CiteScore |
|
||||||||||||||||||||||||||||
PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1744-6872%5BISSN%5D | ||||||||||||||||||||||||||||
中科院SCI期刊分区 ( 2018年新版本) |
|||||||||||||||||||||||||||||
中科院SCI期刊分区 ( 2020年新版本) |
中国学者近期发表的论文 | |
1. | OPG, RANKL, and RANK gene polymorphisms and the bone mineral density response to alendronate therapy in postmenopausal Chinese women with osteoporosis or osteopenia. Author: Zheng H, Wang C, He JW, Fu WZ, Zhang ZL. Journal: Pharmacogenet Genomics. 2016 Jan;26(1):12-9. doi: 10.1097/FPC.0000000000000181. PubMed |
2. | Effects of the selected cytochrome P450 oxidoreductase genetic polymorphisms on cytochrome P450 2B6 activity as measured by bupropion hydroxylation. Author: Lv J, Hu L, Zhuo W, Zhang C, Zhou H, Fan L. Journal: Pharmacogenet Genomics. 2016 Feb;26(2):80-7. doi: 10.1097/FPC.0000000000000190. PubMed |
3. | A comparison of DMET Plus microarray and genome-wide technologies by assessing population substructure. Author: Jackson JN, Long KM, He Y, Motsinger-Reif AA, McLeod HL, Jack J. Journal: Pharmacogenet Genomics. 2016 Jan 1. [Epub ahead of print] PubMed |
4. | Association of KCNQ1 polymorphisms with gliclazide efficacy in Chinese type 2 diabetic patients. Author: Duan F, Guo Y, Zhang L, Chen P, Wang X, Liu Z, Hu Y, Chen S, Chen D. Journal: Pharmacogenet Genomics. 2016 Feb 10. [Epub ahead of print] PubMed |
5. | Effect of folic acid intervention on the change of serum folate level in hypertensive Chinese adults: do methylenetetrahydrofolate reductase and methionine synthase gene polymorphisms affect therapeutic responses? Author: Qin X, Li J, Cui Y, Liu Z, Zhao Z, Ge J, Guan D, Hu J, Wang Y, Zhang F, Xu X, Wang X, Xu X, Huo Y. Journal: Pharmacogenet Genomics. 2012 Jun;22(6):421-8. doi: 10.1097/FPC.0b013e32834ac5e8. PubMed |
6. | Integrating interacting drugs and genetic variations to improve the predictability of warfarin maintenance dose in Chinese patients. Author: Zhong SL, Yu XY, Liu Y, Xu D, Mai LP, Tan HH, Lin QX, Yang M, Lin SG. Journal: Pharmacogenet Genomics. 2012 Mar;22(3):176-82. doi: 10.1097/FPC.0b013e32834f45f9. PubMed |
7. | Effects of CYP2C19 variant alleles on postclopidogrel platelet reactivity and clinical outcomes in an actual clinical setting in China. Author: Wu H, Qian J, Xu J, Sun A, Sun W, Wang Q, Ge J. Journal: Pharmacogenet Genomics. 2012 Dec;22(12):887-90. doi: 10.1097/FPC.0b013e328359253a. PubMed |
8. | Pharmacogenetics of P450 oxidoreductase: implications in drug metabolism and therapy. Author: Hu L, Zhuo W, He YJ, Zhou HH, Fan L. Journal: Pharmacogenet Genomics. 2012 Nov;22(11):812-9. doi: 10.1097/FPC.0b013e328358d92b. PubMed |
|
|